New Delhi, March 20 -- A laser-sharp focus on the US market in a world being reshaped by artificial intelligence has cast shadows over three Indian tech services companies catering to healthcare and life sciences companies.

Lack of diversified businesses, policy uncertainty in the Donald Trump era, and the challenges of GenAI pose major risks for Sagility Ltd, Indegene Ltd, and Inventurus Knowledge Solutions Ltd, all of which listed on the stock exchanges in the past year, analysts said. Most of their revenue comes from offering customer and software services to clients in the US healthcare sector.

At least three experts are circumspect about the prospects of these companies because most of their revenue comes from offering customer and...